Altered peptide ligands: Prospects for immune intervention in autoimmune disease

European Journal of Immunogenetics

Volumn 24, Issue 2, 1997, Pages 155-167

  Fairchild, P J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; EPITOPE; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNITY; ETIOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0030888333     PISSN: 09607420     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2370.1997.00263.x     Document Type: Note

References (65)

1. ALCAMÍ, A. & SMITH, L. (1995) Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunology Today, 16, 474.
2. ALEXANDER, J., SNOKE, K., RUPPERT, J. SIDNEY, J., WALL, M., SOUTHWOOD, S., OSEROFF, C., ARRHENIUS, T., GAETA, F.C.A., COLÓN, S.M., GREY, H.M. & SETTE, A. (1993) Functional consequences of engagement of the TCR by low affinity ligands. Journal of Immunology, 150, 1.
3. BERTOLETTI, A., SETTE, A., CHISARI, F.V., PENNA, A., LEVRERO, M., DE CARLI, M., FIACCADORI, F. & FERRARI, C. (1994) Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T-cells. Nature, 369, 407.
4. BEVAN, M.J., HOGQUIST, K.A. & JAMESON, S.C. (1994) Selecting the T cell receptor repertoire. Science, 264, 796.
5. BLUESTONE, J.A., JAMESON, S., MILLER, S. & DICK, R. (1992) Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition. Journal of Experimental Medicine, 176, 1757.
6. BREWERTON, D.A., CAFFREY, M., HART, F.D. JAMES, D.C.O., NICHOLLS, A. & STURROCK, R.D. (1973) Ankylosing spondylitis and HL-A 27. Lancet, i, 904.
7. BROCKE, S., GIJBELS, K., ALLEGRETTA, M., FERBER, I., PIERCY, C., BLANKENSTEIN, T., MARTIN, R., UTZ, U., KARIN, N., MITCHELL, D., VEROMAA, T., WAISMAN, A., GAUR, A., CONLON, P., LING, N., FAIRCHILD, P.J., WRAITH, D.C., O'GARRA, A., FATHMAN, C.G. & STEINMAN, L. (1996) Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature, 379, 343.
8. + T cells by a self-derived peptide. Nature, 378, 295.
9. CATIPOVIC, B., DAL PORTO, J., MAGE, M., JOHANSEN, T.E. & SCHNECK, J.P. (1992) Major histocompatibility complex conformational epitopes are peptide specific. Journal of Experimental Medicine, 176, 1611.
10. DAVENPORT, M.P. (1995) Antagonists or altruists: do viral mutants modulate T-cell responses? Immunology Today, 16, 432.
11. + population. Science, 260, 98.
12. DE MAGISTRIS, M.T., ALEXANDER, J., COGGESHALI, M., ALTMAN, A., GAETA, F.C.A., GREY, H.M. & SETTE, A. (1992) Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 68, 625.
13. EVAVOLD, B.D. & ALLEN, P.M. (1991) Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science, 252, 1308.
14. EVAVOLD, B.D., SLOAN-LANCASTER, J. & ALLEN, P.M. (1993a) Tickling the TCR: selective T cell functions stimulated by altered peptide ligands. Immunology Today, 14, 602.
15. EVAVOLD, B.D., SLOAN-LANCASTER, J., HSU, B.L. & ALLEN, P.M. (1993b) Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. Journal of Immunology, 150, 3131.
16. EVAVOLD, B.D., SLOAN-LANCASTER, J. & ALLEN, P.M. (1994) Antagonism of superantigen-stimulated helper T cell clones and hybridomas by altered peptide ligand. Proceedings of the National Academy of Sciences, 91, 2300.
17. EVAVOLD, B.D., SLOAN-LANCASTER, J., WILSON, K.J., ROTHBARD, J.B. & ALLEN, P.M. (1995) Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity, 2, 655.
18. FAIRCHILD, P.J., THORPE, C.J., TRAVERS, P.J. & WRAITH, D.C. (1994) Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease. Immunology, 81, 487.
19. FRANCO, A., SOUTHWOOD, S., ARRHENIUS, T., KUCHROO, V.K., GREY, H.M., SETTE, A. & ISHIOKA, G.Y. (1994) T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis. European Journal of Immunology, 24, 940.
20. FRANCO, A., FERRARI, C., SETTE, A. & CHISARI, F.V. (1995) Viral mutations, T cell receptor antagonism and escape from the immune response. Current Opinion in Immunology, 7, 524.
21. b. Science, 257, 919.
22. HOGQUIST, K.A., JAMESON, S.C., HEATH, W.R., HOWARD, J.L., BEVAN, M.J. & CARBONE, F.R. (1994) T cell receptor antagonist peptides induce positive selection. Cell, 76, 17.
23. HSU, B.L., EVAVOLD, B.D. & ALLEN, P.M. (1995) Modulation of T cell development by an endogenous altered peptide ligand. Journal of Experimental Medicine, 181, 805.
24. JAMESON, S.C., CARBONE, F.R. & BEVAN, M.J. (1993) Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. Journal of Experimental Medicine, 177, 1541.
25. JAMESON, S.C., HOGQUIST, K.A. &. BEVAN, M.J. (1994) Specificity and flexibility in thymic selection. Nature, 369, 750.
26. JAMESON, S.C. & BEVAN, M.J. (1995) T cell receptor antagonists and partial agonists. Immunity, 2, 1.
27. KARIN, N., MITCHELL, D.J., BROCKE, S., LING, N. & STEINMAN, L. (1994) Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon-γ and TNFα production. Journal of Experimental Medicine, 180, 2227.
28. KATZ-LEVY, Y., KIRSHNER, S.L., SELA, M. & MOZES, E. (1993) Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs. Proceedings of the National Academy of Sciences, 90, 7000.
29. KERSH, G.J. & ALLEN, P.M. (1996) Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands. Journal of Experimental Medicine, 184, 1259.
30. KLENERMAN, P., ROWLAND-JONES, S., MCADAM, S., EDWARDS, J., DAENKE, S., LALLOO, D., KÖPPE, B., ROSENBERG, W., BOYD, D., EDWARDS, A., GIANGRANDE, P., PHILLIPS, R.E. & MCMICHAEL, A.J. (1994) Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature, 369, 403.
31. KLENERMAN, P., MEIER, U-C., PHILLIPS, R.E. & MCMICHAEL, A.J. (1995) The effect of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to HIV. European Journal of Immunology, 25, 1927.
32. KUCHROO, V.K., GREER, J.M., KAUL, D., ISHIOKA, G., FRANCO, A., SETTE, A., SOBEL, R.A. & LEES, M.B. (1994) A single TCR antagonist peptide inhibits experimental autoimmune encephalomyelitis mediated by a diverse T cell repertoire. Journal of Immunology, 153, 3326.
33. LEHMANN, P.V., SERCARZ, E.E., FORSTHUBER, T., DAYAN, C.M. & GAMMON, G. (1993) Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunology Today, 14, 203.
34. LUND, T., O'REILLY, L., HUTCHINGS, P., KANAGAWA, O., SIMPSON, E., GRAVELY, R., CHANDLER, P., DYSON, J., PICARD, J.K., EDWARDS, A., KIOUSSIS, D. & COOKE, A. (1990) Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified 1-Aβ chain or normal I-E α-chain. Nature, 345, 727.
35. LYONS, D.S., LIEBERMAN, S.A., HAMPL, J., BONIFACE, J.J., CHIEN, Y., BERG, L.J. & DAVIS, M.M. (1996) A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity, 5, 53.
36. MADDEN, D.R., GARBOCZI, D.N. & WILEY, D.C. (1993) The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2. Cell, 75, 693.
37. MADRENAS, J., WANGE, R.L., WANG, J.L., ISAKOV, N., SAMELSON, L.E. & GERMAIN, R.N. (1995) ζ phosphorylation without ZAP-70 activation by TCR antagonists or partial agonists. Science, 267, 515.
38. MAEURER, M.J., CHAN, H-W., KARBACH, J., SALTER, R.D., KNUTH, A., LOTZE, M.T. & STORKUS, W.J. (1996) Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes. European Journal of Immunology, 26, 2613.
39. MATSUOKA, T., KOHROGI, H., ANDO, M., NISHIMURA, Y. & MATSUSHITA, S. (1996) Altered TCR ligands affect antigen-presenting cell responses. Up-regulation of IL-12 by an analogue peptide. Journal of Immunology, 157, 4837.
40. MEIER, U-C., KLENERMAN, P., GRIFFIN, P., JAMES, W., KÖPPE, B., LARDER, B., MCMICHAEL, A. & PHILLIPS, R. (1995) Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science. 270, 1360.
41. NEPOM, G.T. & ERLICH, H. (1991) MHC class II molecules and autoimmunity. Annual Reviews of Immunology, 9, 493.
42. NICHOLSON, L.B., GREEK, J.M., SOBEL, R.A., LEES, M.B. & KUCHROO, V.K. (1995) An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity, 3, 397.
43. OSTROV, D., KRIEGER, J., SIDNEY, J., SETTE, A. & CONCANNON, P. (1993) T cell receptor antagonism mediated by interaction between TCR junctional residues and peptide antigen analogues. Journal of Immunology, 150, 4277.
44. PFEIFFER, C., STEIN, J., SOUTHWOOD, S., KETELAAR, H., SETTE, A. & BOTTOMLY, K. (1995) Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. Journal of Experimental Medicine, 181, 1569.
45. PIRCHER, H., MOSKOPHIDIS, D., ROHRER, U., BURKI, K., HENGARTNER, H. & ZINKERNAGEL, R.M. (1990) Viral escape by selection of cytotoxic T-cell resistant virus variants in vivo. Nature, 346, 629.
46. g7 β-chain diminished the spontaneous incidence of insulin-dependent diabetes mellitus. Journal of Immunology, 154, 5567.
47. RABINOWITZ, J.D., BEESON, C., WÜLFING, C., TATE, K., ALLEN, P.M., DAVIS, M.M. & MCCONNELL, H.M. (1996) Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity, 5, 125.
48. RACIOFFI, L., RONCHESE, F., MATIS, L.A. & GERMAIN, R.N. (1993) Peptide-MHC class II complexes With mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. Journal of Experimental Medicine, 177, 1047.
49. + T cells in response to antagonist ligands. Journal of Experimental Medicine, 184, 149.
50. RENARD, V., DELON, J., LUESCHER, I.F., MALISSEN, B., VIVIER, E. & TRAUTMANN, A. (1996) The CD8β polypeptide is required for the recognition of an altered peptide ligand as an agonist. European Journal of Immunology, 26, 2999.
51. RUPPERT, J., ALEXANDER, J., SNOKE, K., COGGESHALL, M., HERBERT, E., MCKENZIE, D., GREY, H.M. & SETTE, A. (1993) Effect of T cell receptor antagonism on interaction between T cells and antigen presenting cells and on T cell signaling events. Proceedings of the National Academy of Sciences, 90, 2671.
52. SCHLOSSTEIN, L., TERASAKI, P.I., BLUESTONE, R. & PEARSON, C.M. (1973) High association of an HL-A antigen, W27, with ankylosing spondylitis. New England Journal of Medicine, 288, 704.
53. SLOAN-LANCASTER, J., EVAVOLD, B.D. & ALLEN, P.M. (1993) Induction of T cell anergy by altered T cell receptor ligand on live antigen presenting cells. Nature, 363, 156.
54. SLOAN-LANCASTER, J., EVAVOLD, B.D. & ALLEN, P.M. (1994a) Th2 cell clonal anergy as a consequence of partial activation. Journal of Experimental Medicine, 180, 1195.
55. SLOAN-LANCASTER, J., SHAW, A.S., ROTHBARD, J.B. & ALLEN, P.M. (1994b) Partial T cell signaling: altered phospho-ζ and lack of Zap70 recruitment in APL-induced T cell anergy. Cell, 79, 913.
56. SLOAN-LANCASTER, J., STEINBERG, T.H. & ALLEN, P.M. (1996) Selective activation of the calcium signaling pathway by altered peptide ligands. Journal of Experimental Medicine, 184, 1525.
57. SNOKE, K., ALEXANDER, J., FRANCO, A., SMITH, L., BRAWLEY, J.V., CONCANNON, P., GREY, H.M., SETTE, A. & WENTWORTH, P. (1993) The inhibition of different T cell lines specific for the same antigen with TCR antagonist peptides. Journal of Immunology, 151, 6815.
58. TIAN, J., LEHMANN, P.V. & KAUFMAN, D.L. (1994) T cell cross-reactivity between Coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. Journal of Experimental Medicine, 180 (1979).
59. TODD, J.A., ACHA-ORBEA, H., BELL, J.I., CHAO, N., FRONEK, Z., JACOB, C.O., MCDERMOTT, M., SINHA, A.A., TIMMERMAN, L., STEINMAN, L. & MCDEVITT, H.O. (1988) A molecular basis for MHC class II-associated autoimmunity. Science, 240, 1003.
60. TODD, J.A., BELL, J.I. & MCDEVITT, H.O. (1987) HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature, 329, 599.
61. VIDAL, K., HSU, B.L., WILLIAMS, C.B. & ALLEN, P.M. (1996) Endogenous altered peptide ligands can affect peripheral T cell responses. Journal of Experimental Medicine, 183, 1311.
62. VIOLA, A. & LANZAVECCHIA, A. (1996) T cell activation determined by T cell receptor number and tunable thresholds. Science, 273, 104.
63. WAUBEN, M.H.M., BOOG, C.J.P., VAN DER ZEE, R., JOOSTEN, I., SCHLIEF, A. & VAN EDEN, W. (1992) Disease inhibition by MHC binding peptide analogues of disease-associated epitopes: more than blocking alone. Journal of Experimental Medicine, 176, 667.
64. WINDHAGEN, A., SCHOLZ, C., HÖLLSBERG, P., FUKAURA, H., SETTE, A. & HAFLER, D.A. (1995) Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity, 2, 373.
65. WUCHERPFENNIG, K.W. & STROMINGER, J.L. (1995) Selective binding of self peptides to disease associated MHC molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. Journal of Experimental Medicine, 181, 1597.